Bicyclo-pyrazole derivatives active as kinase inhibitors,...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/4162 (2006.01) C07D 487/04 (2006.01)

Patent

CA 2518395

Compounds which are pyrrolo-pyrazole derivatives and pharmaceutically acceptable salts thereof, together with the process for their preparation and pharmaceutical compositions thereof are disclosed; these compounds or compositions are useful in the treatment of diseases caused by and/or associated with an altered protein kinase activity such as cancer, cell proliferative disorders, Alzheimer's disease, viral infections, auto-immune diseases and neurodegenerative disorders.

Cette invention, qui concerne certains composés, des dérivés de pyrrolo-pyrazol et leurs sels acceptable du point de vue pharmaceutique, a également trait au procédé permettant de les préparer ainsi qu'à des compositions pharmaceutiques les contenant. Ces composés ou ces compositions se révèlent des plus utiles dans le traitement d'états pathologiques causés par une modification de l'activité de la protéine kinase ou associés à celle-ci, notamment le cancer, des troubles de la prolifération cellulaire, la maladie d'Alzheimer, des infections virales, des maladies auto-immunes et des troubles neurodégénératifs.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Bicyclo-pyrazole derivatives active as kinase inhibitors,... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bicyclo-pyrazole derivatives active as kinase inhibitors,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bicyclo-pyrazole derivatives active as kinase inhibitors,... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1359626

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.